Shilpa Medicare has received approval from Securities Issue Committee of the Board to raise fund through Qualified Institutional Placement (QIP). Its board has approved the floor price for the issue being Rs 477.33 per Equity Share for the issue. Additionally, the company has authorized the opening of the issue on April 8, 2024.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
